Emmaus Life Sciences, Inc. today announced that Yutaka Niihara, M.D., M.P.H, Chairman and Chief Executive Officer of Emmaus, will present a company overview at the H.C. Wainwright BioConnect Conference, being held virtually, January 10-13, 2022
Read More
Analysis Indicates that Patients Requiring Blood Transfusions and Receiving Endari Required ~43% Fewer Units of Red Blood Cells
Read More
Emmaus invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
Read More
Emmaus Life Sciences, Inc. today announced that data on Endari® has been accepted for a poster presentation at the 63rd American Society of Hematology (ASH) Annual Meeting and Exhibition.
Read More
Emmaus Life Sciences, Inc. today reported financial results for the quarter and nine months ended September 30, 2021.
Read More